TKUN.TA

Tikun Olam-Cannbit Pharmaceuticals Ltd
Tel AvivILAEQUITY DELAYED
Last price
125.30
■ 0.00 (0.00%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
Prev close
125.30
Day high
139.40
Day low
100.00
Volume
33.16K
Market cap
P/E (TTM)
52W range
100.00 – 2,000,000.00

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+16.14% +17.2%
1M
-57.91% -61.4%
3M
-91.45% -94.0%
6M
-93.29% -105.4%
YTD
-94.05% -106.2%
1Y
-96.49% -116.8%
3Y
-98.76% -174.1%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on TKUN.TA open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 3 quarters
Blank means not reported, not zero
Line item20252024202320222021YoY
Total revenue $9.10M$34.95M$44.23M$49.30M -74.0%
Operating revenue $9.10M$34.95M$44.23M$49.30M -74.0%
Cost of revenue $8.22M$36.17M$45.98M$46.86M -77.3%
Gross profit $880.00K-$1.22M-$1.76M$2.43M +172.3%
Research & development $0$832.00K$3.89M$5.16M -100.0%
Selling, general & admin $3.75M$4.84M$8.49M$4.24M -22.5%
Total operating expense $10.47M$13.45M$26.71M$29.10M -22.2%
Operating income -$9.59M-$14.67M-$28.47M-$26.67M +34.6%
Net interest income -$1.08M-$1.88M-$2.17M-$1.68M +42.4%
Pre-tax income -$15.82M-$40.10M-$93.99M-$49.14M +60.6%
Tax provision $0$0$25.00K$12.00K
Net income -$15.85M-$40.10M-$88.89M-$48.23M +60.5%
Net income to common -$15.85M-$40.10M-$88.89M-$48.23M +60.5%
Basic EPS -47.90-141.00-94.81-78.00
Diluted EPS -47.90-141.00-94.81-78.00
EBIT -$14.70M-$38.22M-$91.69M-$47.37M +61.5%
EBITDA -$2.21M-$8.62M-$32.98M$4.83M +74.3%
Basic shares 837.26K630.17K507.94K420.13K
Diluted shares 837.26K630.17K507.94K420.13K

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
74,760.00
-99.83% from price
SMA 20
129,122.50
-45.40% from price
SMA 50
284,179.00
-75.19% from price
SMA 100
592,874.50
-99.98% from price
SMA 200
953,124.75
-92.60% from price
EMA 12
91,627.95
-99.86% from price
EMA 26
152,665.03
-99.92% from price
EMA 50
282,020.36
-99.96% from price
RSI (14)
28.3
Oversold
MACD (12,26,9)
-61,037.08
Hist 5,323.14
ATR (14)
30,700.00
43.55% of price
Realised vol 30D
218.9%
Annualised
Bollinger upper
250,702.72
20, 2σ
Bollinger lower
7,542.28
20, 2σ
50 / 200 cross
Death
284,179.00 vs 953,124.75
Trend bias
Below 200
-92.60%

Options chain

Account required
Expiry
Spot 125.30
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.14
Less volatile than market
Correlation to SPY
-0.01
Largely independent
Realised vol 30D
218.9%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-97.2%
Peak to trough
Max drawdown 5Y
-99.8%
Peak to trough
ATR 14
30,700.00
43.55% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.